Masimo (MASI) Return on Capital Employed (2010 - 2026)
Masimo's (MASI) quarterly Return on Capital Employed came in at 23.0% in Q2 2026, up 1841.0% year-on-year from 1.18% in Q2 2025, and up 2.86% quarter-over-quarter from 22.36% in Q1 2026.
Masimo (MASI) Return on Capital Employed (2010 - 2026) Analysis & Trends
Masimo's Return on Capital Employed history runs 17 years deep, the most recent figure standing at 23.0% for Q2 2026.
- On a quarterly basis, Return on Capital Employed rose 1841.0% year-over-year to 23.0% in Q2 2026; TTM through Apr 2026 was 23.0%, a 1841.0% increase from a year earlier, with the FY2026 full-year figure at 17.31%, up 1447.0% from the prior year.
- Return on Capital Employed advanced to 23.0% in Q2 2026 per MASI's latest filing, from 22.36% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 23.0% in Q2 2026 and bottomed at 2.81% in Q4 2024.
- The 5-year median for Return on Capital Employed is 9.5% (2025), against an average of 10.93%.
- Across the five-year window, Return on Capital Employed plunged 876 bps in 2022 and jumped 1955 bps in 2026, its largest moves.
- Year by year, Return on Capital Employed stood at 11.5% in 2022, then slumped by 41 bps to 6.76% in 2023, then tumbled by 58 bps to 2.81% in 2024, then soared by 219 bps to 8.95% in 2025, then soared by 157 bps to 23.0% in 2026.
- Per Business Quant, the three latest MASI Return on Capital Employed figures stand at 23.0% (Q2 2026), 22.36% (Q1 2026), and 8.95% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 24.24% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.38% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.30% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn | 23.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 23.00% |
| Jan 3, 2026 | 22.36% |
| Sep 27, 2025 | 8.95% |
| Jun 28, 2025 | 6.29% |
| Mar 29, 2025 | 4.59% |
| Dec 28, 2024 | 2.81% |
| Sep 28, 2024 | 8.78% |
| Jun 29, 2024 | 8.14% |
| Mar 30, 2024 | 7.26% |
| Dec 30, 2023 | 6.76% |
| Sep 30, 2023 | 10.05% |
| Jul 1, 2023 | 10.97% |
| Apr 1, 2023 | 10.31% |
| Dec 31, 2022 | 11.50% |
| Oct 1, 2022 | 8.84% |
| Jul 2, 2022 | 12.05% |
| Apr 2, 2022 | 16.42% |
| Jan 1, 2022 | 17.69% |
| Oct 2, 2021 | 17.60% |
| Jul 3, 2021 | 17.99% |